Norway· NO-ID_6223ACEB-17FB-44C9-AFFF-12DE453B7778
Euphrasia wala
A without product containing euphrasia ferm 33c dil. d2, rosae aetheroleum dil. d7 (hab, vs. 5a, lsg. d1 mit ethanol 94% (m/m)), registered in Norway by Wala.
Checked against FEST (Norway) on
Informational only — not a medical device.
The record
At a glance
FEST (Norway)- Active substance
- Euphrasia Ferm 33c Dil. D2, Rosae Aetheroleum Dil. D7 (Hab, Vs. 5a, Lsg. D1 Mit Ethanol 94% (M/M))
- Manufacturer
- Wala
- Country
- Norway (NO)
- ATC code
- WITHOUT
- ATC class
- WITHOUT
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 2
- no_merkevare_idID_6223ACEB-17FB-44C9-AFFF-12DE453B7778
- no_varenummer3570565 x 0.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under WITHOUT
Without, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/526ab889-2643-45b9-bc10-6829be1d4c37 GET /v1/drugs/526ab889-2643-45b9-bc10-6829be1d4c37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Ikke relevant",
"merkevare_id": "ID_6223ACEB-17FB-44C9-AFFF-12DE453B7778",
"name_form_strength": "Euphrasia wala øyedr, oppl",
"prescription_group": "C"
}See everything about euphrasia ferm 33c dil. d2, rosae aetheroleum dil. d7 (hab, vs. 5a, lsg. d1 mit ethanol 94% (m/m)).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.